1. Home
  2. SLN vs GCBC Comparison

SLN vs GCBC Comparison

Compare SLN & GCBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Silence Therapeutics Plc American Depository Share

SLN

Silence Therapeutics Plc American Depository Share

HOLD

Current Price

$5.75

Market Cap

236.2M

Sector

Health Care

ML Signal

HOLD

Logo Greene County Bancorp Inc.

GCBC

Greene County Bancorp Inc.

HOLD

Current Price

$22.35

Market Cap

374.8M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
SLN
GCBC
Founded
1994
1889
Country
United Kingdom
United States
Employees
116
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
236.2M
374.8M
IPO Year
N/A
1998

Fundamental Metrics

Financial Performance
Metric
SLN
GCBC
Price
$5.75
$22.35
Analyst Decision
Buy
Analyst Count
6
0
Target Price
$39.67
N/A
AVG Volume (30 Days)
168.0K
8.7K
Earning Date
01-01-0001
04-22-2026
Dividend Yield
N/A
1.76%
EPS Growth
N/A
26.21
EPS
N/A
1.13
Revenue
N/A
$4,117,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$20.04
Revenue Growth
N/A
11.06
52 Week Low
$1.97
$20.00
52 Week High
$7.78
$26.50

Technical Indicators

Market Signals
Indicator
SLN
GCBC
Relative Strength Index (RSI) 59.50 44.17
Support Level $5.07 $21.39
Resistance Level $6.10 $23.35
Average True Range (ATR) 0.49 0.92
MACD 0.16 -0.13
Stochastic Oscillator 65.37 24.18

Price Performance

Historical Comparison
SLN
GCBC

About SLN Silence Therapeutics Plc American Depository Share

Silence Therapeutics PLC is a biotechnology company focused on discovering and developing novel molecules incorporating short-interfering ribonucleic acid or siRNA. Using its mRNAi GOLD platform, the company has generated siRNA product candidates both for internal development pipeline as well as for out-licensed programs with third-party collaborators. Its wholly owned pipeline is focused on three therapeutic areas: cardiovascular disease, hematology, and rare diseases. The different product candidates in its pipeline are Divesiran (SLN124), a siRNA product candidate that has the potential to treat several hematological disorders; Zerlasiran (SLN360), being developed as a potential treatment to reduce cardiovascular issues; SLN-312; SLN-548; and multiple other programs.

About GCBC Greene County Bancorp Inc.

Greene County Bancorp Inc is a holding firm. Its primary business involves overseeing and directing the business of The Bank of Greene County and monitoring its cash position. Through its directly and indirectly owned subsidiaries, the company engages in attracting retail deposits, along with funds generated from operations and borrowings, predominantly in one to four-family residential mortgage loans, commercial real estate mortgage loans, consumer loans, home equity loans, and commercial business loans. It also serves local municipalities' banking needs and operates a real estate investment trust.

Share on Social Networks: